FdaApplication
NDA 219531
Identifiers
- fda_app_no: NDA219531
Properties
| Property | Value |
|---|---|
| applicant_name | BRILLIAN PHARMA INC |
| application_type | NDA |
| approval_date | 2025-07-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SDAMLO | AMLODIPINE BESYLATE | EQ 2.5MG BASE/BOT | FOR SOLUTION;ORAL |
| SDAMLO | AMLODIPINE BESYLATE | EQ 5MG BASE/BOT | FOR SOLUTION;ORAL |
| SDAMLO | AMLODIPINE BESYLATE | EQ 10MG BASE/BOT | FOR SOLUTION;ORAL |
3 products